Voice of America interviews GHTC Director Kaitlin Christenson about GHTC's policy report Sustaining progress: Creating US policies to spur global health innovation, which warns that US budget cuts could put global health R&D progress at risk.
In an op-ed in The Hill, GHTC Director Kaitlin Christenson, along with Jim Connoly, President and CEO of Aeras, and Dr. Mel Spigelman, President and CEO of TB Alliance, express concerns about declining funding for global health R&D. They argue that with more products entering late-stage development, it is critical that governments continue to invest to get these products across the finish line.
With Secretary of State Hillary Clinton poised to deliver a major speech on HIV/AIDS later this week, GlobalPost features clips from GHTC's video series in which prominent Americans are asked why they think Americans should care about global health R&D.
In response to the release of the movie Contagion, which chronicles a fictitious global disease pandemic, GHTC Director Kaitlin Christenson writes in The Hill about the real world threat of infectious diseases and the critical importance of investing in the development of new vaccines, diagnostics, drugs, and other health tools to counter these threats.